-
Cliché but True: Keep Calm and Carry On
Key Points: In today’s Recommendations for Industry, we discuss the current progression of COVID and the flu and why keeping calm is the phrase of the day. Read more below. Happy Lunar New Year to all our readers! The U.S. FDA has given full approval to Moderna’s COVID-19 vaccine, henceforth known as Spikevax (VOA News,…
-
TAG Holds Guarded Optimism for the Ebbing of Omicron
Key Points: In today’s Recommendations for Industry, we discuss our guarded optimism for the ebbing of Omicron. Read more below. OSHA Withdraws Its Workplace Vaccine Rule. On Tuesday, OSHA announced its withdrawal of the November 5, 2021, ETS issued to “protect unvaccinated employees of large employers (100 or more employees) from the risk of contracting…
-
What Does an Endemic COVID Really Mean?
Key Points: In today’s Recommendations for Industry, we discuss the ebbing of Omicron and what a shift to an endemic COVID would really mean. Read more below. The FDA is limiting the use of the following two monoclonal antibodies – (a) bamlanivimad and etesevimab and (b) REGEN-COV – to treat COVID-19 as they are “highly…
-
COVID Case Rates Following Predictable Pattern
Key Points: In today’s Recommendations for Industry, we discuss Omicron’s path across the US. Read more below. U.S. hospitals have been inundated with Omicron cases; yet, as the vaccine mandate for healthcare workers becomes effective March 15, there is increasing fear that hospital systems may lose some workers. Additionally, despite signs that Omicron causes milder…
-
Build Your Systems for COVID’s Next Wave
Key Points: In today’s Recommendations for Industry, we discuss the business management of COVID’s next wave … whatever that may be. Read more below. As you’ve most likely heard, the Supreme Court has halted the COVID-19 vaccine rule for U.S. businesses. (AP News). Canada approves of Pfizer’s COVID-19 pill to be used “for adult patients…
-
Even Unrelated Vaccines Can Help Protect Against COVID-19
Key Points: In today’s Recommendations for Industry, we discuss new studies suggesting that flu shots, measles vaccines, and the common cold can cross-protect against COVID. Read more below. A recently published study found that SARS-CoV-2 infection during pregnancy is associated with an increased risk for adverse pregnancy outcomes, including induced abortion, cesarean sections, preterm birth…
-
Yes, Omicron is Here but No Need for Panic
Key Points: In today’s Recommendations for Industry, we discuss the Omicron variant. Read more below. On Sunday Jan 09, the CDC updated its “Quarantine and Isolation” webpage to allow readers to better understand what to do. The updates have extra charts for readers to better understand when to test and when traveling can be allowed.…
-
Back to Basics: Looking Ahead & Looking Back
Key Points: In today’s Recommendations for Industry, we discuss the updated CDC isolation guidelines (coupled with antigen testing) while reflecting on how long this new COVID wave might last. Read more below. COVID-19 cases in the U.S. are at the highest level recorded through the pandemic. This can be reflected and seen in this week’s…
-
Testing Before Return from Isolation
Key Points: In today’s Recommendations for Industry, we discuss testing symptomatic employees prior to their return to work. Read more below. South Africa has declared that they’ve moved through the peak of their fourth COVID-19 wave that has been driven by the Omicron variant. Additionally, it has removed its curfew. The U.S. has topped 2…
-
Preparing for Increased Absenteeism in January
Key Points: In today’s Recommendations for Industry, we discuss increased absenteeism in the new year and look at this week’s Risk Matrix. Read more below. OSHA Withdrew its COVID-19 Healthcare ETS a week after it had reached its six-month expiration date, with the exception of the recordkeeping requirements, which remain in place under a separate provision of…